Navigation Links
Thyroid Function at High End of Normal Tied to Miscarriage Risk
Date:6/22/2010

Pregnant women should be screened according to stricter standards, experts suggest

TUESDAY, June 22 (HealthDay News) -- Testing in the upper half of what is currently considered a normal range for thyroid function can nonetheless be problematic for pregnant women, who face an increased risk for miscarriage as a result, new research suggests.

The study is the first to link what has previously been considered normal thyroid function to miscarriage risk, according to co-investigator Dr. Alex Stagnaro-Green, a senior associate dean for education at the George Washington University School of Medicine and Health Sciences in Washington, D.C.

The newly observed risk does not involve the presence of thyroid peroxidase antibodies, something that prior research has linked to a threat for miscarriage. An underactive thyroid has also been associated with risk of miscarriage, the study authors noted in a news release from the Endocrine Society.

"There has been an ongoing discussion as to whether or not the normal range for thyroid function tests is too broad," Stagnaro-Green said in the news release. "This study provides clear evidence that the normal range for thyroid function tests during pregnancy needs to be redefined."

The findings are scheduled for presentation Tuesday at the Endocrine Society Annual Meeting and Expo in San Diego.

The researchers' concerns center on the use of the thyroid stimulating hormone blood test. Since 2007, pregnant women reading above the upper limit of 2.5 milli-international units per liter (mIU/L) in the first trimester and 3 mIU/L in the second and third trimesters have been deemed to have an "underactive thyroid," and thus a higher risk for miscarriage.

However, the authors pointed out that many doctors do not actually follow this guideline, instead relying on the non-pregnant "normal range" marker of 4.5 or 5 mIU/L as an upper limit.

Stagnaro-Green and colleagues sought to get a handle on what range is, in fact, safe for pregnant women, by tracking the first-trimester thyroid tests and pregnancy outcomes of more than 4,100 women attending two community hospitals in Italy.

The team found that having a high-end normal-range thyroid reading (above 2.5, but below 5) did not increase the risk for having a pre-term delivery, however, miscarriage rates among women with a high-normal range were "significantly higher" (about 6 percent versus 3.6 percent) than for women with the recommended below-2.5 thyroid reading for pregnant women.

"This leads us to think that all pregnant women should be screened for thyroid function and any abnormalities treated," Stagnaro-Green concluded in the news release.

More information

For more on thyroid disease in pregnancy, visit the U.S. National Endocrine and Metabolic Diseases Information Service.



-- Alan Mozes



SOURCE: The Endocrine Society, news release, June 22, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Flame Retardant May Up Risk of Thyroid Problems in Pregnancy
2. Flame retardant linked to altered thyroid hormone levels during pregnancy
3. SNM 2010 image of the year: Molecular imaging shows parathyroid disease in greater detail
4. Thyroid ultrasound takes center stage at Caesars Palace
5. Experts Divided on Whether to Treat Thyroid Cancer
6. Demonstrated in vivo the transfer of maternal thyroid hormones to the fetus
7. Thyroid condition increases stroke risk in young adults
8. Overactive Thyroid Linked to Stroke in Young Adults
9. Thyroid hormone analogue for treating high cholesterol
10. Thyroid Hormone Analogue for Treating High Cholesterol
11. Thyroid Disease: The Hidden Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Thyroid Function at High End of Normal Tied to Miscarriage Risk
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: